Robert T.

Bureau Chief

Preston's Summary

Robert T. is a Bureau Chief at The Dallas Morning News. He specializes in medicine and healthcare, with a focus on oncology, immunotherapy, gene therapy, and various aspects of biology and life sciences. His work has been featured in numerous publications, including BMC, Psychology Today, and The Lancet, among others.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Austin, United States (Local)

Coverage Attributes:

Beta
Informative: 44 %
Data Driven: 38 %
Cites Data: 14 %
Press Release: 2 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Biology & Life Sciences
  • Biotechnology
  • Chemistry
  • Immunology
  • Immunotherapy
  • Materials Science
  • Neuroscience
  • Oncology

Pitching Insights

Robert T.'s coverage predominantly focuses on local government and politics, with a substantial emphasis on legal policy regulation. Given this focus, he would likely be receptive to pitches that provide insights into local legislative developments, particularly those related to education and scientific research.

Due to the significant portion of his articles being based on data citations, Robert may also welcome pitches that offer new or unique datasets relevant to his areas of coverage. Additionally, as there is some information about medical studies in his coverage attributes but not included in the topics covered section; it's possible that he may have an interest in receiving pitches related to healthcare policies or scientific breakthroughs within Texas or Dallas.

When pitching Robert T., consider aligning your expertise with local political matters such as educational policy changes or innovative scientific research happening within Texas or Dallas.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Most recent topics
Not enough data
Sophia Ktori
Freelance Writer and Editor Specialising in Life Sciences, Pharmaceuticals and Biotechnology
Most recent topics
Not enough data